Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)
Jolien F. van Nimwegen, Esther Mossel, Greetje S. van Zuiden, Robin F. Wijnsma, Konstantina Delli, Alja J. Stel, Bert van der Vegt, Erlin A. Haacke, Lisette Olie, Leonoor I. Los, Gwenny M. Verstappen, Sarah Pringle, Fred K. L. Spijkervet, Frans G. M. Kroese, Arjan Vissink, Suzanne Arends, Hendrika Bootsma
Topics & Concepts
MedicineAbataceptPlaceboRheumatismInternal medicineRheumatologyAdverse effectRandomized controlled trialPhysical therapySurgeryRituximabPathologyAlternative medicineLymphomaSalivary Gland Disorders and FunctionsRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus Research